TCR2

TCR2

A development stage company focusing on development of biological drugs and engineering T cells for cancer therapy.

HQ location
Cambridge, United States
Website
Launch date
Employees
Market cap
$58.1m
Enterprise value
($46m)
Share price
$1.48 TCRR
Authorizing premium user...